Predict the Direction of Biochemical Reactions Before Running Full Experimental Series
BinomLabs helps determine the likely direction of biochemical reactions by comparing the physical parameters of initial, intermediate and final molecular complexes. Instead of relying only on endpoint experimental readouts, our platform evaluates affinity, dissociation constant, enthalpy, entropy, thermal dissociation and residue-level electrostatic interactions to identify whether a complex is more likely to form, decay or transition into another biochemical state.
This is especially valuable when experimental data show that a reaction occurred, but do not clearly explain the dominant molecular pathway or the direction of complex formation.
BinomLabs positions this task around reaction direction, formation/decay of biological complexes and affinity ranking using calculated physical parameters such as dissociation constant, entropy, enthalpy, thermal dissociation and electrostatic interactions.
This is especially valuable when experimental data show that a reaction occurred, but do not clearly explain the dominant molecular pathway or the direction of complex formation.
BinomLabs positions this task around reaction direction, formation/decay of biological complexes and affinity ranking using calculated physical parameters such as dissociation constant, entropy, enthalpy, thermal dissociation and electrostatic interactions.
It is estimated that over 80% of human proteins participate in approximately 74,000–650,000 protein-protein interactions (PPIs). Mapping PPI networks and determining the three-dimensional (3D) structures of protein complexes elucidate the molecular mechanisms of biological processes and provide functional insights for poorly characterized proteins, as their functions can often be inferred from their interacting partners.
BinomLabs proposes to determine the affinity and stability of initial, intermediate and final molecular formations.
We focuses on biochemical pathways of complex biochemical formation, taking into account various thermodynamic parameters that change as the complexity and molecular weight of complex molecules increase.
We conducted a study of the co-direction of changes in thermodynamic quantities such as lg[Kd], TΔS, Δ(ΔW), and lg(cond(W)) during the transition from a monomer to a dimer and then to a trimer and tetramer.
We assume that the co-direction of changes in thermodynamic quantities as the final molecular formation being achieved signals a higher affinity of molecules among themselves than there is for a biochemical formation, which is characterized by the lack of coordination of the biochemical pathway directions of the final molecular compound.
Below are the pain points and challenges for various experimental types of equipment, in the solution of which the BinomLabs platform and our specialists can help you
Here’s a structured breakdown of pain points and challenges inherent to using protein–protein for interaction studies.
Thermodynamic Stability & Interactions
Common Problems:
Common Problems:
Common Problems:
Common Problems:
Common Problems:
Common Problems:
Thermodynamic Stability & Interactions
Common Problems:
- Difficulty isolating pure conformational changes from binding events.
- Buffer effects can mask or alter thermodynamic signatures.
- Temperature sensitivity of proteins may lead to denaturation before meaningful data is collected.
- Inaccurate baseline correction due to instrument drift.
- Misinterpretation of ΔG, ΔH, ΔS when multiple equilibria are involved.
- Solvent reorganization or ionization effects not accounted for.
Common Problems:
- Overlapping transitions in multi-domain proteins complicate analysis.
- Irreversible denaturation prevents repeat scans or comparative studies.
- Low sensitivity for weakly interacting systems.
- Poor sample-to-buffer matching leads to noisy baselines.
- Air bubbles or improper sealing of sample cells.
- Instrument calibration drift or thermal lag.
Common Problems:
- Weak binding interactions may produce undetectable heat changes.
- Dilution heat or buffer mismatch can obscure binding signals.
- High sample consumption limits repeatability.
- Incorrect ligand/protein concentration or stoichiometry.
- Baseline instability due to poor thermal equilibration.
- Injection artifacts from syringe backlash or air bubbles.
Common Problems:
- Non-specific binding to sensor surfaces.
- Mass transport limitations skew kinetic data.
- Regeneration issues can degrade sensor surface over time.
- Poor immobilization strategy (e.g., random orientation of proteins).
- Inaccurate reference subtraction or drift in baseline.
- Temperature fluctuations affecting refractive index.
Common Problems:
- Signal instability due to environmental vibrations or temperature.
- Low sensitivity for small molecule interactions.
- Surface fouling affects reproducibility.
- Improper sensor calibration or alignment.
- Optical noise from ambient light or poor shielding.
- Inconsistent sample flow or air bubbles in microfluidics.
Common Problems:
- Crystallization bottlenecks for membrane or flexible proteins.
- Conformational heterogeneity complicates interpretation.
- Sample degradation during long data collection times.
- Misassignment of electron density or ambiguous NMR peaks.
- Radiation damage in X-ray studies.
- Overfitting models to noisy or incomplete data.
Here's a detailed breakdown of common problems and sources of error for each of these biophysical techniques. These methods are powerful for studying macromolecular behavior, but they come with their own technical and interpretive challenges.
Analytical Ultracentrifugation (AUC)
Common Problems:
Common Problems:
Common Problems:
Common Problems:
Analytical Ultracentrifugation (AUC)
Common Problems:
- Sample heterogeneity complicates sedimentation profiles.
- Low signal-to-noise ratio for dilute samples.
- Time-consuming data acquisition and analysis.
- Incorrect rotor speed or temperature control affects sedimentation rates.
- Optical misalignment in absorbance or interference optics.
- Improper baseline subtraction or buffer mismatch.
- Aggregation or precipitation during the run distorts results.
Common Problems:
- Photobleaching reduces signal over time.
- Background fluorescence interferes with measurements.
- Limited dynamic range for large macromolecules.
- Improper fluorophore labeling (e.g., multiple labels per molecule).
- Instrument miscalibration of polarization filters.
- Temperature fluctuations affecting rotational diffusion.
- Incorrect assumptions about molecular shape or viscosity.
Common Problems:
- Sensitivity to dust or aggregates skews size distribution.
- Polydispersity complicates interpretation.
- Fluorescence interference in DLS if fluorophores are present.
- Poor sample filtration or handling.
- Incorrect refractive index or viscosity settings.
- Multiple scattering in concentrated samples.
- Fluorescence quenching or spectral overlap in dual-mode setups.
Common Problems:
- High sensitivity to noise and fluctuations.
- Difficulty analyzing polydisperse samples.
- Photobleaching or blinking of fluorophores.
- Incorrect confocal volume calibration.
- Fluorescent impurities or aggregates dominate signal.
- Poor fitting of autocorrelation curves.
- Inaccurate diffusion models for complex systems.
Pharma and biotech spend tens of billions each year on in‑vitro work, where variability and low first‑try success increse cost and timelines. BinomLabs applies state‑of‑the‑art ML to deliver experiment prognoses that align with lab data up to R = 0.93, demonstrated on real in‑vitro studies.
With this guidance, teams typically reduce ~10 experiments to 3–4, lifting the proportion of successful first attempts and freeing capital for the highest‑value questions. We enhance expert judgment—turning every scientist into a faster, more precise decision‑maker.
With this guidance, teams typically reduce ~10 experiments to 3–4, lifting the proportion of successful first attempts and freeing capital for the highest‑value questions. We enhance expert judgment—turning every scientist into a faster, more precise decision‑maker.
Are you part of a biochemical or pharmacological laboratory and looking for highly effective results?
Join our free pilot program featuring an advanced AI platform that predicts experimental data with 70%-90% correlation, reducing the number of required experiments by 60%!
Benefits:
Save time and resources.
Enhance research efficiency.
Focus on breakthroughs while AI handles the heavy lifting.
📩 Apply now to explore this game-changing technology and collaborate with us!
Join our free pilot program featuring an advanced AI platform that predicts experimental data with 70%-90% correlation, reducing the number of required experiments by 60%!
Benefits:
Save time and resources.
Enhance research efficiency.
Focus on breakthroughs while AI handles the heavy lifting.
📩 Apply now to explore this game-changing technology and collaborate with us!
🚨 We’re Hiring Pilot Projects! 🚨 FREE PILOT project for biochemistry labs!
Reduce in vitro cost
phone nomber: 053-382-60-75
koshlan.tetiana@gmail.com
koshlan.tetiana@gmail.com
- Enzyme properties and the effect of substrate concentration
- Protein assay and standard curve generation
- Thin-layer chromatography
- ELISA.
- DNA/RNA Sequencing.
- Nutrition.
- Gel Electrophoresis.
- Antibodies & Antigens.
- Blotting Methods.
Benefit from modern AI-BinomLab technologies:
AI Platform for Accurate Experimental Data Prediction:
- activity of the complex,
- cell growth,
- affinity, IС50, Kd,
- survival,
- toxicity,
- drug efficacy,
- effect of protein modification and drug addition,
- structural changes,
- unfolding,
- denaturation,
- molecular weight of the complex, aggregation
- entropy change,
- enthalpy change,
- numerical stability parameter,
- potential energy,
- calculated Kd,
- heat maps,
- numerical values
- monomers, dimers,
- trimers, tetramers,
- protein-protein interaction
- peptides,
- protein+inhibitors+atoms,
- Antibody-Antigen
- RNA molecules
AI Platform for Predicting Structure, Composition, and Chemical Reactions of Substances
Suitable for the following molecules:
You will receive the following set of calculated data:
records data, and studies the functions, chemical processes
New! Tubulin Inhibitors: Decades of controversy.
In the last decade, conflicting data on the effectiveness of Rigosertib have accumulated. We make a Comparative numerical analysis: Rigosertib/ ON01500?
Let us conduct a comparative computational analysis for tubulin tetramers containing small chemical molecules (inhibitors): GTP, Rig, oN015000
Arrows indicate the calculated values of the movement of biochemical processes within the framework of the given formations.
The system is in search of molecular formations that meet the above conditions of thermodynamic equilibrium. Learn More
In the last decade, conflicting data on the effectiveness of Rigosertib have accumulated. We make a Comparative numerical analysis: Rigosertib/ ON01500?
Let us conduct a comparative computational analysis for tubulin tetramers containing small chemical molecules (inhibitors): GTP, Rig, oN015000
Arrows indicate the calculated values of the movement of biochemical processes within the framework of the given formations.
The system is in search of molecular formations that meet the above conditions of thermodynamic equilibrium. Learn More
Comparative numerical analysis: Rigosertib/ ON01500?
How much does it cost to use AI in biochemical experiments?
Modern technologies will allow you to get a large set of preliminary data for the price of 2.49 Euros for each small protein or peptide when ordering a study on a hundred similar amino acid sequences.
| |
Leave your request/questions and our specialists will contact you shortly on all issues | Meet the group, explore the school, and get a free consultation |
